Molecular determinants of Ebola virus virulence in mice

被引:172
作者
Ebihara, Hideki
Takada, Ayato
Kobasa, Darwyn
Jones, Steven
Neumann, Gabriele
Theriault, Steven
Bray, Mike
Feldmann, Heinz
Kawaoka, Yoshihiro
机构
[1] Univ Tokyo, Inst Med Sci, Tokyo, Japan
[2] Publ Hlth Agcy Canada, Special Pathogens Prorgram, Natl Microbiol Lab, Winnipeg, MB, Canada
[3] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan
[4] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada
[5] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada
[6] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, Madison, WI USA
[7] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
[8] NIAID, Off Clin Res, NIH, Bethesda, MD 20892 USA
[9] Int Res Ctr Infect Dis, Tokyo, Japan
关键词
D O I
10.1371/journal.ppat.0020073
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Zaire ebolavirus (ZEBOV) causes severe hemorrhagic fever in humans and nonhuman primates, with fatality rates in humans of up to 90%. The molecular basis for the extreme virulence of ZEBOV remains elusive. While adult mice resist ZEBOV infection, the Mayinga strain of the virus has been adapted to cause lethal infection in these animals. To understand the pathogenesis underlying the extreme virulence of Ebola virus ( EBOV), here we identified the mutations responsible for the acquisition of the high virulence of the adapted Mayinga strain in mice, by using reverse genetics. We found that mutations in viral protein 24 and in the nucleoprotein were primarily responsible for the acquisition of high virulence. Moreover, the role of these proteins in virulence correlated with their ability to evade type I interferon-stimulated antiviral responses. These findings suggest a critical role for overcoming the interferon-induced antiviral state in the pathogenicity of EBOV and offer new insights into the pathogenesis of EBOV infection.
引用
收藏
页码:705 / 711
页数:7
相关论文
共 37 条
  • [1] Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level
    Alazard-Dany, N
    Volchkova, V
    Reynard, O
    Carbonnelle, C
    Dolnik, O
    Ottmann, M
    Khromykh, A
    Volchkov, VE
    [J]. JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 1247 - 1257
  • [2] The Ebola virus VP35 protein functions as a type IIFN antagonist
    Basler, CF
    Wang, XY
    Mühlberger, E
    Volchkov, V
    Paragas, J
    Klenk, HD
    Garcia-Sastre, A
    Palese, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12289 - 12294
  • [3] Basler CF, 2004, EBOLA AND MARBURG VIRUSES: MOLECULAR AND CELLULAR BIOLOGY, P305
  • [4] The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3
    Basler, CF
    Mikulasova, A
    Martinez-Sobrido, L
    Paragas, J
    Mühlberger, E
    Bray, M
    Klenk, HD
    Palese, P
    García-Sastre, A
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (14) : 7945 - 7956
  • [5] A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever
    Bray, M
    Davis, K
    Geisbert, T
    Schmaljohn, C
    Huggins, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) : 651 - 661
  • [6] Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus
    Bray, M
    Hatfill, S
    Hensley, L
    Huggins, JW
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2001, 125 (04) : 243 - 253
  • [7] The role of the Type I interferon response in the resistance of mice to filovirus infection
    Bray, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 2001, 82 : 1365 - 1373
  • [8] Elaboration of laboratory strains of Ebola virus and study of pathophysiological reactions of animals inoculated with these strains
    Chepurnov, AA
    Zubavichene, NM
    Dadaeva, AA
    [J]. ACTA TROPICA, 2003, 87 (03) : 321 - 329
  • [9] TEMPERATURE-SENSITIVE MUTANTS OF RABIES VIRUS IN MICE - MUTANT (TS 2) REVERTANT MIXTURE SELECTIVELY PATHOGENIC BY PERIPHERAL ROUTE OF INOCULATION
    CLARK, HF
    OHTANI, S
    [J]. INFECTION AND IMMUNITY, 1976, 13 (05) : 1418 - 1425
  • [10] Pathogenesis of experimental Ebola virus infection in guinea pigs
    Connolly, BM
    Steele, KE
    Davis, KJ
    Geisbert, TW
    Kell, WM
    Jaax, NK
    Jahrling, PB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S203 - S217